Leidos delivered strong Q2’25 results with record EPS, margin expansion, and robust cash flow. Read why LDOS stock is a buy ...

Key Points Non-GAAP earnings per share and GAAP revenue exceeded analyst forecasts for Q2 2025, despite falling sales volumes. Management sharply reduced its outlook for full-year 2025 net sales ...

Key Points GAAP earnings per share and revenue missed analyst expectations for Q2 2025 and declined from the prior year. Gross margin (GAAP) improved by 1.7 percentage points in Q2 2025 compared to ...

Q2 2025 Management View Jason Potter, President and CEO, reported, "We delivered solid second quarter results that exceeded our outlook. Net sales of $1.18 billion grew 4.5% over last year, while ...

Q2 2025 Management View George LeMaitre, CEO, stated that "Q2 was strong across the board, with sales up 15%, a 70% gross ...

Crexendo (CXDO) reported $16.55 million in revenue for the quarter ended June 2025, representing a year-over-year increase of ...

Spirit AeroSystems reported 1.6 billion in revenue for the second quarter of 2025, driven by increased production of Boeing ...

AMD reported its Q2 earnings after the bell on Tuesday, posting mixed results but offering a solid Q3 outlook.

Q3 guidance was set for EPS of $3.01–$3.07, organic growth of 8%–9%, and segment operating margins of 24.1%–24.5%. Full-year adjusted EPS guidance was raised to $11.97–$12.17, representing 12% growth ...

EVgo (EVGO) delivered earnings and revenue surprises of +23.08% and +13.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Adjusted EPS accretion -- Management projects $0.63 to $0.70 of accretion to Sterling's adjusted EPS on an annualized basis ...

Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78.